Sort
10,766 grants matching “checkpoint inhibitor”
CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures
$16,970,131Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Molecular Regulation of B cells and T cells in Human SLE
$6,250,527Ignacio E. Sanz · Emory University · U19 · FY2023 · AI
Molecular Regulation of B cells and T cells in Human SLE
$5,901,416Ignacio E. Sanz · Emory University · U19 · FY2021 · AI
Cancer Immunologic Data Commons
$5,785,000Ethan Cerami · Dana-Farber Cancer Inst · U24 · FY2017 · CA
Cancer Center Support Grant
$5,317,547Michael A Teitell · University Of California Los Angeles · P30 · FY2025 · CA
Molecular Regulation of B cells and T cells in Human SLE
$5,194,108Ignacio E. Sanz · Emory University · U19 · FY2019 · AI
Molecular Regulation of B cells and T cells in Human SLE
$5,067,462Ignacio E. Sanz · Emory University · U19 · FY2020 · AI
Cancer Immunotherapy
$4,841,882James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$4,810,822Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2020 · CA
Molecular Regulation of B cells and T cells in Human SLE
$4,808,545Ignacio E. Sanz · Emory University · U19 · FY2022 · AI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$4,614,298Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Cancer Immunology Research Program
$4,530,485Marcus W Bosenberg · Yale University · P30 · FY2023 · CA
CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures
$4,449,073Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$4,353,842Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2021 · CA
Cancer Immunotherapy
$4,195,237James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$4,095,431Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$4,075,119Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Cancer Immunotherapy
$4,037,445James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Mechanisms of Exosome Driven Immunoregulation of Cancer Progression
$3,950,956Robert H Blelloch · University Of California, San Francisco · U01 · FY2019 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$3,837,391Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Cytokine immunotherapies for melanoma
$3,810,235Marcus W Bosenberg · Yale University · U01 · FY2019 · CA
Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors
$3,793,439Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2025 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$3,704,144Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2024 · CA
Genes and signals controlling mammalian hematopoiesis.
$3,610,441Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$3,580,727Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA